Raia Drogasil S.A. (BVMF:RADL3)

Market Cap	32.12B +5.4%
Revenue (ttm)	46.53B +18.0%
Net Income	1.34B +9.7%
EPS	0.81 +12.0%
Shares Out	1.75B
PE Ratio	21.62
Forward PE	17.01
Dividend	0.39 (2.13%)
Ex-Dividend Date	Jul 6, 2026

Volume	21,716,500
Open	18.35
Previous Close	18.14
Day's Range	17.93 - 18.64
52-Week Range	16.21 - 27.42
Beta	0.02
Analysts	Buy
Price Target	25.97 (+41.37%)
Earnings Date	Nov 3, 2026

About Raia Drogasil

Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics and specialty medicines in Brazil. The company sells its products through stores, telesales, and call centers. Raia Drogasil S.A. was founded in 1905 and is headquartered in São Paulo, Brazil.

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 1905
• Employees: 75,594
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: RADL3

Financial Performance

In 2025, Raia Drogasil's revenue was 44.25 billion, an increase of 13.84% compared to the previous year's 38.87 billion. Earnings were 1.30 billion, an increase of 8.08%.

Analyst Summary

According to 15 analysts, the average rating for RADL3 stock is "Buy." The 12-month stock price target is R$25.97, which is an increase of 41.37% from the latest price.

Price Target

R$25.97

(41.37% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 30, 2026

Data Sources Report a data error